Hallux, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2012-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.halluxinc.com
To Evaluate Hallux Terbinafine Subungual Gel (HSG) in the Treatment of Onychomycosis
Phase 2
Active, not recruiting
- Conditions
- Onychomycosis of Toenail
- Interventions
- First Posted Date
- 2021-11-26
- Last Posted Date
- 2023-08-07
- Lead Sponsor
- Hallux, Inc.
- Target Recruit Count
- 35
- Registration Number
- NCT05135910
- Locations
- 🇺🇸
OrthoArizona - East Valley Foot & Ankle Specialists, Mesa, Arizona, United States
🇺🇸Front Range Foot and Ankle Clinic, Parker, Colorado, United States
🇺🇸Oregon Dermatology & Research Center, Portland, Oregon, United States
Efficacy, Safety, and Tolerability of HTS-519 Insert in Patients With Toenail Fungus of the Big Toenail
Phase 2
Completed
- Conditions
- Onychomycosis
- Interventions
- Drug: HTS-519 Insert
- First Posted Date
- 2016-06-14
- Last Posted Date
- 2021-11-02
- Lead Sponsor
- Hallux, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT02798380
- Locations
- 🇺🇸
OrthoArizona - East Valley Foot & Ankle Specialists, Mesa, Arizona, United States
© Copyright 2025. All Rights Reserved by MedPath